Normally, patients fast before surgery to reduce this risk, but GLP-1 medications can cause food to remain in the stomach longer than expected, increasing the chance of aspiration even after fasting
These medications mimic the action of naturally occurring GLP-1, a hormone that regulates appetite, insulin secretion, and various metabolic processes
Clinical trials of GLP-1 patches have consistently shown lower and more variable absorption compared to subcutaneous injections, meaning patients experience less predictable appetite suppression and metabolic effects
Additionally, hyperglycemia is associated with decreased nerve fiber diameter, reduced number of large myelinated fibers, and decreased nerve conduction velocity, which are more pronounced in cases of early-onset hyperglycemia (Strand et al., 2024)
Conclusion Our study stresses the pivotal role of a new metabolism-based therapy using GLS1 as a target of a dendriplex PURE G4 -LA 12 -anti- GLS1 -siRNA proposed as a new tool for gene modulation therapy
This stacking builds your muscle significantly while at the same time cutting down body fat